Hermansky-Pudlak Syndrome 1
Oncology·MeSH: Methylenetetrahydrofolate reductase deficiency
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Hermansky-Pudlak Syndrome 1?
There are 1 clinical trial targeting Hermansky-Pudlak Syndrome 1 tracked by BioSniper.
What is the prevalence of Hermansky-Pudlak Syndrome 1?
The estimated prevalence of Hermansky-Pudlak Syndrome 1 is approximately 30.0 per 100,000 population.
Deep-dive into Hermansky-Pudlak Syndrome 1
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis